These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35203508)

  • 21. MicroRNA-216b-3p inhibits lung adenocarcinoma cell growth via regulating PDZ binding kinase/T-LAK-cell-originated protein kinase.
    Chai Y; Xue H; Wu Y; Du X; Zhang Z; Zhang Y; Zhang L; Zhang S; Zhang Z; Xue Z
    Exp Ther Med; 2018 Jun; 15(6):4822-4828. PubMed ID: 29805502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer.
    Park JH; Lin ML; Nishidate T; Nakamura Y; Katagiri T
    Cancer Res; 2006 Sep; 66(18):9186-95. PubMed ID: 16982762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baicalin suppresses lung cancer growth by targeting PDZ-binding kinase/T-LAK cell-originated protein kinase.
    Diao X; Yang D; Chen Y; Liu W
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant expression of PDZ-binding kinase/T-LAK cell-originated protein kinase modulates the invasive ability of human pancreatic cancer cells via the stabilization of oncoprotein c-MYC.
    Hinzman CP; Aljehane L; Brown-Clay JD; Kallakury B; Sonahara F; Goel A; Trevino J; Banerjee PP
    Carcinogenesis; 2018 Dec; 39(12):1548-1559. PubMed ID: 30165468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential.
    Huang H; Lee MH; Liu K; Dong Z; Ryoo Z; Kim MO
    Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34066486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Integrative Pan-Cancer Analysis of PBK in Human Tumors.
    Wen H; Chen Z; Li M; Huang Q; Deng Y; Zheng J; Xiong M; Wang P; Zhang W
    Front Mol Biosci; 2021; 8():755911. PubMed ID: 34859049
    [No Abstract]   [Full Text] [Related]  

  • 27. PBK/TOPK mediates geranylgeranylation signaling for breast cancer cell proliferation.
    Dou X; Wei J; Sun A; Shao G; Childress C; Yang W; Lin Q
    Cancer Cell Int; 2015; 15():27. PubMed ID: 25745361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cells.
    Simons-Evelyn M; Bailey-Dell K; Toretsky JA; Ross DD; Fenton R; Kalvakolanu D; Rapoport AP
    Blood Cells Mol Dis; 2001; 27(5):825-9. PubMed ID: 11783945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of TOPK/PBK in children with malignant lymphoma or reactive lymphoid hyperplasia].
    Tian X; He XL; Yuan XY; Zou RY; Zou H; You YL; Chen KK; Zhu CG
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Mar; 20(3):214-217. PubMed ID: 29530122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth.
    Kim DJ; Li Y; Reddy K; Lee MH; Kim MO; Cho YY; Lee SY; Kim JE; Bode AM; Dong Z
    Cancer Res; 2012 Jun; 72(12):3060-8. PubMed ID: 22523035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PBK/TOPK overexpression and survival in solid tumors: A PRISMA-compliant meta-analysis.
    Xu M; Xu S
    Medicine (Baltimore); 2019 Mar; 98(10):e14766. PubMed ID: 30855480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the oncogenic kinase TOPK/PBK as a master mitotic regulator of C2H2 zinc finger proteins.
    Rizkallah R; Batsomboon P; Dudley GB; Hurt MM
    Oncotarget; 2015 Jan; 6(3):1446-61. PubMed ID: 25575812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response.
    Ayllón V; O'connor R
    Oncogene; 2007 May; 26(24):3451-61. PubMed ID: 17160018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.
    Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
    Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omics- and Pharmacogenomic Evidence for the Prognostic, Regulatory, and Immune-Related Roles of PBK in a Pan-Cancer Cohort.
    Liu Y; Xiang J; Peng G; Shen C
    Front Mol Biosci; 2021; 8():785370. PubMed ID: 34859058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PBK/TOPK expression during TPA-induced HL-60 leukemic cell differentiation.
    Liu YH; Gao XM; Ge FM; Wang Z; Wang WQ; Li XY
    Asian Pac J Cancer Prev; 2012; 13(5):2145-8. PubMed ID: 22901184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PDZ binding kinase (PBK) is a theranostic target for nasopharyngeal carcinoma: driving tumor growth via ROS signaling and correlating with patient survival.
    Wang MY; Lin ZR; Cao Y; Zheng LS; Peng LX; Sun R; Meng DF; Xie P; Yang JP; Cao L; Xu L; Huang BJ; Qian CN
    Oncotarget; 2016 May; 7(18):26604-16. PubMed ID: 27049917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell growth inhibition by 3-deoxysappanchalcone is mediated by directly targeting the TOPK signaling pathway in colon cancer.
    Zhao R; Huang H; Choi BY; Liu X; Zhang M; Zhou S; Song M; Yin F; Chen H; Shim JH; Bode AM; Dong Z; Lee MH
    Phytomedicine; 2019 Aug; 61():152813. PubMed ID: 31035049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.